Pacific Biosciences Clocks 14% Jump In Q1 Revenues
Pacific Biosciences of California Inc's (NASDAQ:PACB) Q1 sales increased 14% Y/Y to $33.2 million, driven by sales of instruments and consumables and beating the consensus of $32.82 million. Instrument revenue was $15.6 million, compared with $14.9 million a year ago. Consumables revenue was $12.7 million, up from $10.4 million in Q1 2021.…
Benzinga ·
Benzinga
